Carlos Roberto Ribeiro Carvalho
Overview
Explore the profile of Carlos Roberto Ribeiro Carvalho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baldi B, Feitosa P, Rubin A, Amaral A, Freitas C, Costa C, et al.
J Bras Pneumol
. 2025 Feb;
51(1):e20240378.
PMID: 39936727
Lymphangioleiomyomatosis (LAM) is a rare disease, characterized as a low-grade neoplasm with metastatic potential that mainly affects women of reproductive age, in which there is proliferation of atypical smooth muscle...
2.
Maia I, Kawano-Dourado L, Tramujas L, de Oliveira N, Souza R, Signorini D, et al.
JAMA
. 2024 Dec;
333(10):875-890.
PMID: 39657981
Importance: High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) are commonly used respiratory support therapies for patients with acute respiratory failure (ARF). Objective: To assess whether HFNO is noninferior to...
3.
Queiroz D, da Silva C, Oliveira M, Amaral A, Carvalho C, Salge J, et al.
Lung
. 2024 Oct;
202(6):757-765.
PMID: 39402376
Background: Lymphangioleiomyomatosis (LAM) is a rare (twenty-one per million female inhabitants) neoplastic cystic lung disease that impairs health-related quality of life (HRQoL). However, the factors associated with impaired quality of...
4.
Carvalho C, Lamas C, Visani de Luna L, Chate R, Salge J, Sawamura M, et al.
Lancet Reg Health Am
. 2024 Apr;
33:100733.
PMID: 38680501
Background: COVID-19 lung sequelae can impact the course of patient lives. We investigated the evolution of pulmonary abnormalities in post-COVID-19 patients 18-24 months after hospital discharge. Methods: A cohort of...
5.
Freitas D, Costa E, Zimmermann N, Gois L, Anjos M, Lima F, et al.
PLoS One
. 2024 Mar;
19(3):e0299607.
PMID: 38452031
Background: The emergence of SARS-CoV-2 variants led to subsequent waves of COVID-19 worldwide. In many countries, the second wave of COVID-19 was marked by record deaths, raising the concern that...
6.
Oliveira M, Wanderley M, Freitas C, Kairalla R, Chate R, Amaral A, et al.
ERJ Open Res
. 2024 Mar;
10(2).
PMID: 38444661
Background: Lymphangioleiomyomatosis (LAM) is a rare disease that can occur sporadically (S-LAM) or associated with the tuberous sclerosis complex (TSC-LAM). The natural history of LAM is not completely understood, including...
7.
Carvalho C, Lamas C, Chate R, Salge J, Sawamura M, de Albuquerque A, et al.
PLoS One
. 2023 Jan;
18(1):e0280567.
PMID: 36662879
Background: Coronavirus disease (COVID-19) survivors exhibit multisystemic alterations after hospitalization. Little is known about long-term imaging and pulmonary function of hospitalized patients intensive care unit (ICU) who survive COVID-19. We...
8.
Carvalho C, Chate R, Sawamura M, Garcia M, Lamas C, Cardenas D, et al.
BMJ Open
. 2022 Jun;
12(6):e059110.
PMID: 35697456
Objective: This study aimed to propose a simple, accessible and low-cost predictive clinical model to detect lung lesions due to COVID-19 infection. Design: This prospective cohort study included COVID-19 survivors...
9.
Amaral A, Carvalho C, Baldi B
J Bras Pneumol
. 2022 Mar;
48(1):e20220046.
PMID: 35293492
No abstract available.
10.
Baldi B, Radzikowska E, Cottin V, Dilling D, Ataya A, Carvalho C, et al.
Chest
. 2021 Dec;
161(6):1589-1593.
PMID: 34942174
No abstract available.